23andme

By Laura Lovett 04:01 pm January 23, 2020
23andMe has laid off 100 employees across its consumer business, the genomics company confirmed to MobiHealthNews.   This news come amidst disappointing sales numbers, according to CNBC, which first reported the story. In an interview with CNBC’s Chrissy Farr, 23andMe CEO Anne Wojcicki discussed potential factors contributing to what she sees as a market cooldown, top of the list being customers...
By Dave Muoio 04:11 pm December 11, 2019
Not so fast? Google’s plans to purchase Fitbit will soon be under the US Department of Justice’s lens. According to a New York Post report, the merger raised antitrust flags at both the DOJ and the Federal Trade Commission, with the former federal agency ultimately winning out. The Post’s sources said that both of these agencies are hesitant to allow Google an even greater view into individuals’...
By Tammy Lovell 06:05 am December 6, 2019
Shoppers may come home with more than they bargained for when visiting Waitrose & Partners Canary Wharf, and John Lewis & Partners, White City. As well as bagging their usual products, customers now have the chance to get a personalised DNA report while browsing the London stores.  Two pop-ups from genetic testing pioneer DnaNudge aim to 'nudge' people into make healthier choices by...

Photo credit: Gabe Ginsberg/Getty Images for LARAS

By Laura Lovett 02:13 pm September 26, 2019
23andMe, a frontrunner in the consumer genomics space, is turning its attention to clinical trial recruitment. The company has inked a deal with TrialSpark, a health tech platform that lets providers become clinical trial sites, connecting their customers to the latter’s trial network.  The new deal will use 23andMe’s crowdsourced research platform, which lets its customers opt into research and...
By Dave Muoio 03:36 pm July 11, 2019
Telehealth and mail-order health and wellness consumer brands Hims & Hers have been joined by Dr. Pat Carroll. Formerly a chief medical officer at Walgreens and a 20,000-patient primary care group, Carroll take on a similar role for the growing startup. “Our vision is an ecosystem where people have plenty of options to get the care that’s right for them. Depending on what they need, that...
By Jonah Comstock 01:36 pm May 20, 2019
MyHeritage, an Israeli company that has been doing ancestry-related genetic testing since 2016, has announced a new product that brings the company into the health-focused consumer DNA testing space alongside the likes of 23andMe. MyHeritage DNA Health+Ancestry is a single test that includes a wide-range of genetic aptitudes for possible health conditions: specifically, the company will offer 11...

23andMe kits at a Beverly Hills event in 2017. Credit: Matt Winkelmeyer, Getty Images

By Laura Lovett 03:14 pm April 29, 2019
This morning 23andMe announced that it is teaming up with The Michael J. Fox Foundation for Parkinson’s Research on a new data and analytics platform dedicated to Parkinson’s research.  The new tool, dubbed Fox Insight Data Exploration Network (Fox DEN) is set to include patient surveys, de-identified genetic data and data exploration tools all aimed studying Parkinson’s.  Users who opt into the...
By Jonah Comstock 05:43 am March 27, 2019
Direct-to-consumer gene tests like Ancestry.com and 23andMe are increasingly informing consumers about gene alterations that could signal health risks. But those tests look at only a few positions on particular genes, as opposed to medical sequencing that is much more thorough. And, according to a 2018 study by Ambry Genetics in Genetics in Medicine, these results can be wrong — the study showed...
By Jonah Comstock 01:26 pm March 11, 2019
At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle. To assist with the latter piece,...
By Laura Lovett 04:17 pm January 24, 2019
Apple versus posionous gas. Patently Apple has spotted a newly published patent application that seems to suggest that miniature sensors for poisonous gas may be a feature of future Apple devices. Filled in March of 2018, the application’s diagrams include examples of the sensors housed within an enclosure such as an Apple Watch and describe detection capabilities for “at least one of ozone (O....